Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Capital Expenditures (2016 - 2025)

Bruker (BRKR) has disclosed Capital Expenditures for 16 consecutive years, with $22.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 38.42% year-over-year to $22.6 million, compared with a TTM value of $90.8 million through Dec 2025, down 21.25%, and an annual FY2025 reading of $90.8 million, down 21.25% over the prior year.
  • Capital Expenditures was $22.6 million for Q4 2025 at Bruker, up from $20.9 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $57.7 million in Q3 2022 and bottomed at $16.3 million in Q3 2021.
  • Average Capital Expenditures over 5 years is $26.7 million, with a median of $24.6 million recorded in 2021.
  • The sharpest move saw Capital Expenditures soared 253.99% in 2022, then crashed 53.38% in 2023.
  • Year by year, Capital Expenditures stood at $28.4 million in 2021, then increased by 21.83% to $34.6 million in 2022, then fell by 8.96% to $31.5 million in 2023, then grew by 16.51% to $36.7 million in 2024, then crashed by 38.42% to $22.6 million in 2025.
  • Business Quant data shows Capital Expenditures for BRKR at $22.6 million in Q4 2025, $20.9 million in Q3 2025, and $21.3 million in Q2 2025.